Digestive Enzyme Blend for Abdominal Bloating

The trial aims to test a FODMAP-targeting digestive enzyme blend designed to reduce bloating for individuals who often feel gassy or uncomfortable after eating. The enzymes break down certain carbohydrates (FODMAPs) that can cause bloating and stomach pain. Participants will receive either the enzyme blend or a placebo (an inactive look-alike treatment) to compare effects on their symptoms. This study may suit adults who regularly experience bloating and abdominal pain, especially if current diets or treatments are ineffective. As an unphased trial, it offers participants the chance to contribute to innovative research that could lead to new solutions for digestive discomfort.

The trial requires that you do not use any other digestive enzymes and avoid medications with substantial gastrointestinal side effects. You should also not change your use of probiotics, fiber supplements, laxatives, or antidiarrheals in the 30 days before starting the trial. If you're on medications that affect your gut, you may need to stop or adjust them, so it's best to discuss this with the trial team.

Research has shown that the FODMAP-targeting digestive enzyme blend, such as FODZYME®, is generally well-tolerated by individuals with FODMAP intolerances. In one study, 78% of participants reported less bloating after using the enzyme blend for four weeks, indicating its effectiveness and safety. There is no strong evidence of serious side effects. The enzyme blend breaks down FODMAPs, carbohydrates that can cause bloating and gas, providing relief without the strict rules of a Low FODMAP Diet. While individual experiences may vary, the data supports the enzyme blend as a safe option for managing bloating symptoms.¹²³⁴⁵

Most treatments for abdominal bloating focus on symptom relief through dietary changes or medications that reduce gas. However, this new digestive enzyme blend targets FODMAPs—specific carbohydrates that can ferment in the gut, causing bloating. By directly breaking down these troublesome carbs before they cause discomfort, this treatment offers a proactive approach rather than just addressing symptoms after they occur. Researchers are excited because this could provide more effective and faster relief for those struggling with bloating issues.

This trial will evaluate a FODMAP-targeting digestive enzyme blend for abdominal bloating. Studies have shown that enzyme blends like FODZYME® can significantly improve digestive symptoms. In one study, 72% of participants noticed a clear improvement in their digestive health. Another study found that after four weeks of using this enzyme blend, many people experienced less bloating and stomach discomfort. This enzyme mix breaks down certain carbohydrates (FODMAPs) that can cause gas and bloating before they reach the large intestine. Research suggests this could be an easier option compared to a strict low FODMAP diet, which many find difficult to follow. Participants in this trial will receive both the active enzyme blend and a placebo, allowing for a comprehensive assessment of its effectiveness.¹²⁴⁶⁷